## ValueSet Comparison between http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs vs http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs

### Messages

Error | ValueSet.version | Values for version differ: '3.0.0' vs '4.0.0-cibuild'
Information | ValueSet.date | Values for date differ: '2024-12-12T20:43:36+00:00' vs '2025-11-08T00:09:50+00:00'

### Metadata

Name | Value | Comments
--- | --- | ---
compose.inactive |  |
compose.lockedDate |  |
copyright | This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. |
date | 2024-12-12T20:43:36+00:00 | 2025-11-08T00:09:50+00:00 | Values Differ
description | Value Set for terms that describe a predicted ramification based on the presence of associated molecular finding(s). |
experimental | false |
immutable |  |
jurisdiction |  |
jurisdiction[0] | http://unstats.un.org/unsd/methods/m49/m49.htm#001 |
name | GeneticTherapeuticImplicationsVS |
publisher | HL7 International / Clinical Genomics |
purpose |  |
status | active |
title | Genetic Therapeutic Implications |
url | http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs |
version | 3.0.0 | 4.0.0-cibuild | Values Differ

### Definition

Item | Property | Value | Comments
--- | --- | --- | ---
include | http://loinc.org |  |
Concept | LA10315-2 | Ultrarapid metabolizer |
Concept | LA25391-6 | Normal metabolizer |
Concept | LA25390-8 | Rapid metabolizer |
Concept | LA10317-8 | Intermediate metabolizer |
Concept | LA9657-3 | Poor metabolizer |
Concept | LA19542-2 | Low Risk |
Concept | LA19541-4 | High Risk |
Concept | LA6676-6 | Resistant |
Concept | LA6677-4 | Responsive |
Concept | LA9660-7 | Presumed resistant |
Concept | LA9661-5 | Presumed responsive |
Concept | LA6682-4 | Unknown Significance |
Concept | LA6675-8 | Benign |
Concept | LA6674-1 | Presumed Benign |
Concept | LA9662-3 | Presumed non-responsive |
Concept | LA25392-4 | Increased function |
Concept | LA25393-2 | Normal function |
Concept | LA25395-7 | Decreased function |
Concept | LA25394-0 | Poor function |
include | http://snomed.info/sct |  |
Concept | 444734003 | Does not meet eligibility criteria for clinical trial (finding) |
Concept | 399223003 | Patient eligible for clinical trial (finding) |

### Expansion

Unable to generate expansion - see errors